Despite disruptions to in-person selling and recruitment during the COVID-19 pandemic, USANA has experienced sales gains, according to the company’s recent earnings call. USANA reported $259 million for the second quarter 2020, compared to $256 million for the same quarter the prior year. The company brought in $1.32 in earnings per diluted share, or 13 cents more than expected. USANA projects sales of $1.05 billion to $1.10 billion for full year 2020. Its previous forecast had a range of $1 billion to $1.08 billion. CFO Doug Hekking said that results had been sustained due to demand for its immunity support products. A return to “somewhat normal in mainland China” has also benefited the company, according to CEO Kevin Guest.
earnings
Tupperware Continues Transformation; Herbalife Lowers Guidance; Nu Skin Beats Wall Street Estimates
By David Rauf
We listen in on the public company earnings calls and read the transcripts so you don’t have to. Check back each quarter for our review with insights and takeaways for your own business.
This report includes an update on the earnings calls from Mannatech and Reliv, both of which had revenue losses for the year-end quarter.
Please see the March and April issues for reports from the other public direct selling companies.
Please log in (or register) to continue viewing this content.
By David Rauf
Mannatech and Reliv both report losses in fourth quarter.
Note: We listen in on the public company earnings calls and read the transcripts so you don’t have to. Check back each quarter for our review with insights and takeaways for your own business.
This report includes an update on the earnings calls from Mannatech and Reliv, both of which had revenue losses for the year-end quarter.
Please see the March and April issues for reports from the other public direct selling companies.
Mannatech Inc.
The Flower Mound, Texas-based nutritional supplement maker Mannatech says it successfully launched several new products in 2018—including a global expansion of its signature product line—but reported flat sales figures for 2018. Revenue also decreased during Q4. And the company’s stock dropped by 11 percent to $17.04 in March after reporting earnings, but rebounded to $18.00 by the second week of April.
Please log in (or register) to continue viewing this content.